Myriad Genetics (MYGN) and GSK Unite to Boost HRD Testing
Yahoo Finance · 5 days ago
Search results
We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.
- 40.66Add to watchlist+0.01 (+0.02%)At close:4:00 PM EDTMon. Jun 17, 202440.70 +0.04 (+0.10%)After hrs:7:57 PM EDTMon. Jun 17, 2024Delayed Quote (USD) · Market closed
- Open40.43High40.68Low40.36
- Mkt Cap84.04BP/E (TTM)14.63Div & Yield1.50 & 3.70%
- Prev. Close40.6552 Wk. Low33.6752 Wk. High45.93
What analysts are sayingTop storiesRelated stocks
Home | GSK US. ERG in action. During Pride Month, we are shining the spotlight on our LGBTQ+ ERG, Spectrum. In 1996, a group of GSK staff formed the first Spectrum branch and they have not slowed down since. We now have active branches at each of our US locations. Read our article about Spectrum. Behind the science US edition.
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with global headquarters in London.
From quarterly updates to key announcements, here you can access GSK investor-related information.
Find the latest GSK plc (GSK) stock quote, history, news and other vital information to help you with your stock trading and investing.
GSK has a significant footprint in the US across commercial, R&D, manufacturing, and corporate functions. We employ ~15,000 people across the US and have two corporate hubs. Explore GSK in the US.
Get the latest GSK plc (GSK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
The GSK of today. GSK plc underwent a transformation in 2022, separating its consumer healthcare business to establish Haleon plc as an independent listed company. This marked a new chapter for GSK as a focused biopharma company, dedicated to the development of innovative medicines and vaccines.
Globally, our portfolio spans vaccines, specialty and general medicines, with R&D focused on science of the immune system, human genetics and advanced technologies. GSK has a significant footprint in the US across commercial, R&D, manufacturing, and corporate functions.
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We prioritise innovation in vaccines and specialty medicines to prevent and treat disease. Download.
